Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
about
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomasCHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress responseThe chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer.Sirtuin 2 mutations in human cancers impair its function in genome maintenance.SAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous Recombination.The single-nucleotide polymorphisms in CHD5 affect the prognosis of patients with hepatocellular carcinoma.
P2860
Q26751724-23C5197B-21EC-4D36-97B7-0A30751789ECQ33630872-6EC8F444-0653-4E3F-8717-308AF40090E9Q34313054-BDDF1F94-50EA-46F2-82AB-B784614D339AQ35270535-286E276D-E04E-4D51-A549-18FE7594F9D4Q37225359-2844D7EE-C964-4201-B982-2C8EE0E0602FQ37735355-3696C257-8DFA-46E9-8C53-A1807B4A233EQ38705277-AA1E3F70-4E13-4C5A-BBD2-3F774B9BF8ADQ40082412-8919B2A3-8751-4F26-ACD8-0708FBBE0D8EQ52641593-3EBF395C-126B-4DE8-A8A1-61ABD2E958AA
P2860
Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Low CHD5 expression activates ...... or resected pancreatic cancer.
@en
Low CHD5 expression activates ...... or resected pancreatic cancer.
@nl
type
label
Low CHD5 expression activates ...... or resected pancreatic cancer.
@en
Low CHD5 expression activates ...... or resected pancreatic cancer.
@nl
prefLabel
Low CHD5 expression activates ...... or resected pancreatic cancer.
@en
Low CHD5 expression activates ...... or resected pancreatic cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Low CHD5 expression activates ...... for resected pancreatic cancer
@en
P2093
A V Petrova
B F El-Rayes
B G Pantazides
C A Staley
J C Landry
J W Shelton
P2860
P2888
P304
P356
10.1038/ONC.2013.488
P407
P577
2013-11-25T00:00:00Z
P6179
1026658851